STC1 and neoplasm: Cancer-associated mesothelial cells secrete ANGPTL4 and STC1, which directly drive OvCa, endothelial, and monocyte cell function in the tumor microenvironment, and targeting ANGPTL4 and STC1 interferes with the tumor-promoting capabilities of cancer-associated mesothelial cells.